Deep Patel completed his Doctor of Pharmacy (PharmD) in India, where he spent one year in a multispecialty hospital as a clinical pharmacist intern. He worked in several different departments, including gynecology, pediatric, medical and surgical, where his prime focus was on patient counseling, ADR reporting and helping clinical pharmacists decide effective and economic therapeutic options.
While working toward his PharmD, Patel also completed a prospective and interventional project about type 2 diabetes to determine prevalence rate, risk factors, medication adherence and economic burden in a village in India.
During his work to obtain his master's degree, Patel voluntarily worked on neuroblastoma and associated chemo brain under Dr. Eun-Jung Park’s Lab at Long Island University.
Prior to joining the Indiana Biosciences Research Institute (IBRI), Patel completed an internship from TrueBinding, a biotech company in California, where he researched lymphedema mice models and in vitro aggregation of proteins with various clotting factors on endothelial cells. Cellular changes in various proteins and inflammatory cytokines were observed by IHC/IF.